Good MorningThe rally on Wall Street fizzled on Thursday as investors braced for the September NFP report. The spiking yield on the ten-year treasury has markets nervous the FOMC will hike rates multiple times before it is through, and the NFP report could provide a cause. The ADP report Wednesday was weaker than expected but does not often track in alignment with the NFP: the Challenger, Gray & Christmas report on layoffs and planned hiring shows intent to hire nearly 600,000 seasonal workers this holiday, putting 2023 on track to be the 3rd strongest hiring year on record.
The next test for the market is next week. The PPI and CPI data are due out mid-week and may provide another reason for investors to worry. The latest indications suggest the CPI will accelerate compared to the previous month on a MoM and YoY basis and will lend further evidence that inflation is not tamed.
Also on tap for next week is the start of the Q3 earnings reporting season. The season kicks into high gear on Friday with reports from the major banks. Featured: I interviewed 600 crypto millionaires – here's what's coming (Ad) 
|
Tech | | |
The world will never be able to stop the growing demand - and advancements - coming from the chips and semiconductor industry. This is one of those spaces that can be compared to oil booms in decades past, where new companies get involved to increase production and refinery efficiencies and capabi... Read the Full Story |
|
From Our PartnersAs you may have seen over the last few weeks, I've been giving out special daily setups on my favorite ticker.
We’ve been taking these setups @ 10AM and so far, we've posted 28 different payouts …
Each of which were delivered at exactly 4PM as the market closed.
You see, these setups require zero oversight and have shown the power to deliver in the most chaotic market conditions.
And after a few weeks of fine-tuning … I knew it was time to let you in on The 4 PM Payout Plan.
That's why Jack Carter and I pulled back the curtain to reveal how we've been able to nail in a 96% win rate in the same window the market lost 11 trillion dollars in value. | | | We also revealed how you can find and execute these setups on your own without any help at all. |
|
Stocks | | |
In the past week, growth sectors, as tracked by the Technology Select Sector SPDR Fund (NYSEARCA: XLK) and the Communication Services Select Sector SPDR Fund (NYSEARCA: XLC), have been the strongest performers.
As bonds sell-off, investors are shifting their portfolios from dividend stocks to gro... Read the Full Story |
|
Stocks | | |
The list of Most Upgraded Stocks for October, those stocks with the most upgrades in September, is a surprising lot. The list includes five names with one thing in common: AI. The story is the same whether AI-powered security, AI-powered creative services, or AI-powered business efficiency. These ... Read the Full Story |
|
|
Stocks | | |
The recent flare up in inflation and interest rates are taking a toll on much of the consumer discretionary sector. Since August 1st, department stores, casinos, RV makers and residential construction companies have been some of the stock market’s worst performers. Even high-flying restauran... Read the Full Story |
|
Stocks | | | Wall Street rallied in a whipsaw Friday and erased its morning losses after looking deeper into the nuances of a surprisingly strong report on the U.S. job market. The S&P 500 climbed 1.2% after charging back from an earlier drop of 0.9%. The Dow Jones Industrial Average rose 288 points, or 0.9%... Read the Full Story |
|
|
Markets | | | Asian shares mostly rose in cautious trading Friday after Wall Street drifted to a quiet close on worries about a too-hot U.S. job market.Japan's benchmark Nikkei 225 fell 0.3% to finish at 30,994.67. Australia's S&P/ASX 200 rose 0.4% to 6,954.20. South Korea's Kospi edged up 0.2% to 2,408.73. H... Read the Full Story |
|
Markets | | |
Oil prices corrected in early October, falling 10% from their highs, and Exxon Mobil (NYSE: XOM) with it, but this is not the time to start shedding energy stocks. The price of WTI is up more than 13% from the start of the 3rd quarter and relatively flat compared to the same period last year, sugg... Read the Full Story |
|
Markets | | | The global economy has shown “remarkable resilience’’ but still bears deep scars from the coronavirus pandemic, the war in Ukraine and rising interest rates, the head of the International Monetary Fund said Thursday.“While the recovery from the shocks of the past few years continues, it is slow and ... Read the Full Story |
|
Stocks | | | Surging interest rates are intensifying the challenges for the U.S. economy and threatening to derail the Federal Reserve’s drive to tame inflation without causing a deep recession. Since mid-summer, the yield on the 10-year Treasury note, a benchmark for many loans, has steadily climbed, causing a ... Read the Full Story |
|
Markets | | | An unforeseen burst of hiring last month has lifted hopes that the economy will prove durable once again, even as an array of threats lie ahead. Businesses across the U.S. economy ramped up their hiring in September, defying surging interest rates, financial market turmoil, the ongoing threat of a g... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd. | | View Today's Stock Pick |
|
